Search

everythinglearnresearchcommunity

for

Search:↓

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Ruxolitinib reduced inflammation and improved symptoms in APECED patients but may cause anemia and weight gain.

Baricitinib reduces inflammation and mitochondrial damage in skin cells.

Phenolic compounds from Quercus acutissima leaves, especially casuarinin, may help treat acne.

Upadacitinib improves life quality for Alopecia Areata patients without worsening skin issues.

Accurate diagnosis of alopecia areata incognito requires trichoscopy and histopathology.

Inherited ichthyosis negatively impacts quality of life, affecting daily activities, self-image, and reproductive decisions.

Alopecia areata significantly lowers quality of life, especially in personal and social areas, and more so if the patient is also depressed.

A young woman with a rare hair loss condition improved with steroid and biotin treatment.

Janus kinase inhibitors are effective for severe alopecia areata, promoting hair regrowth.

A new gene mutation causes insulin resistance in a girl and her mother.

Alopecia areata significantly worsens quality of life, suggesting a need for mental health support.

3,4,5-tri-O-caffeoylquinic acid promotes hair growth by activating the β-catenin pathway.

The Thai version of the Family Dermatology Life Quality Index is a reliable and valid tool for assessing the quality of life of patients' families.

Adalimumab significantly improved symptoms and quality of life in two patients with Hidradenitis Suppurativa.

AKN might be a skin marker for metabolic syndrome.

Some natural compounds from Iris plants can block enzymes related to certain disorders, with a few affecting both targeted enzymes.

The document concludes that a new questionnaire to assess mental health in alopecia patients shows low rates of seeking mental health services and support groups.

Alopecia Areata severely impacts mental health, causing anxiety and depression, affecting quality of life.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

Doublebase gel hydrates skin better and is preferred by most users over Aqueous cream.

Medicaid coverage for alopecia areata treatments is inconsistent and often limited.

The engineered yeast strain BLYAS can quickly and sensitively detect androgenic chemicals.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

Adalimumab significantly improved Hidradenitis Suppurativa and quality of life in two patients.

Psychological therapies may improve quality of life for people with alopecia areata.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

Androgenetic alopecia is linked to higher cardiovascular and metabolic risks, possibly due to irisin resistance.

The ABI1 gene contributes to prostate cancer progression and treatment resistance.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.